A Study of ABT-751 in Patients With Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2003

Study Completion Date

February 28, 2005

Conditions
Colorectal Cancer
Interventions
DRUG

ABT-751

Trial Locations (6)

27710

Duke University Medical Center, Durham

53792

University of Wisconsin Medical Center, Madison

60637

University of Chicago Medical Center, Chicago

90089

University of Southern California, Los Angeles

90095-3961

Cancer Institute Medical Group, Santa Monica

60611-5933

Northwestern University, Chicago

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00073138 - A Study of ABT-751 in Patients With Colorectal Cancer | Biotech Hunter | Biotech Hunter